A Busy Week for TITAN MEDICAL INC COM NPV (OTCMKTS:TITXF)

632

TITAN MEDICAL INC COM NPV (OTCMKTS:TITXF) is being mentioned on Street Register for the first time today after the company caught our eye with a couple of different news announcements this week.

TITXF self-identifies as a medical device company focused on the design, development and commercialization of a robotic surgical system for application iyn minimally invasive surgery (“MIS”). The SPORT Surgical System is comprised of a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures.

Earlier this week TITAN MEDICAL INC COM NPV (OTCMKTS:TITXF) reported the successful completion of the world’s first gynecologic, colorectal and urologic single port robotic procedures using the advanced prototype SPORT Surgical System.

David McNally, President and CEO of Titan Medical, said, “We are thrilled to successfully complete our first preclinical single port robotic procedures within the gynecologic, colorectal and urologic surgical disciplines using a fully-functional SPORT system, on time and on plan. We credit the expertise of the surgeons, along with the professional team at Nicholson Center who worked seamlessly with our product development team to accomplish this milestone within the first week of installation. Under the expert guidance of renowned surgeons Dr. Ricardo Estape, Dr. Eduardo Parra-Davila and Dr. Vipul Patel, we confirmed the feasibility of single port abdominal robotic surgery with our unique multi-articulated robotic instruments and 3D high-definition visualization in a variety of surgical procedures. This is a significant step forward for Titan Medical and validates our belief that single port robotic surgery holds tremendous potential to improve patient outcomes in gynecologic, colorectal and urologic surgery.” (Source: OTC Disclosure & News Service)

Later this week, Titan released its second key announcement pertaining to entry into an agreement with Columbia University Medical Center for feasibility and validation studies to support regulatory application for its SPORT Surgical System. These studies, to be performed in Columbia’s surgical simulation center, are expected to commence in the fourth quarter of 2017 and continue into 2018.

David McNally, President and CEO of Titan Medical, said, “We are honored to partner with another leading academic medical center in Columbia University Medical Center, a New York Presbyterian Hospital for continued feasibility and validation studies for Titan’s SPORT system. Through this collaboration, the SPORT system will be installed at the Roy and Diane Vagelos Education Center, a brand new state-of-the-art medical and graduate education center with full access to laboratory facilities as well as Columbia’s multi-specialty and world-renowned surgeons.”

Columbia University Medical center, in the Washington Heights section of Manhattan, is allocated nearly half of Columbia University’s annual budget. Columbia University Medical Center’s assistance in scientific research includes dozens of active programs of study.

Meanwhile TITXF stock has been on a steady incline for several weeks, and these latest revelations have kicked that upswing into a much higher gear. In the month of September alone the stock has traded up from a low of .1076 and run as high as .2902 per share. That works out to an impressive upswing of 169.7% in a relatively short period of time. We’ll definitely want to be on the lookout for continued momentum, and some point, a consolidation could lead to subsequent bounce-play opportunities. Stay locked to Street Register for updates, and we’ll deliver important developments on TITXF as they unfold. In the meantime, if you’ve yet to sign up for our 100% free newsletter, do so now! Just enter your active email address into the box below and submit!

 

Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in TITXF stock, short or long.

 

LEAVE A REPLY